KATEGORIEë
UITSTEKENDE PRODUKTE
Tirzepatide 15mg
Tirzepatide 15mg: Dual-Agonist Research Peptide for Advanced Metabolic Pathway Studies
Tirzepatide 15mg stands as a transformative research tool, combining ultra-high-potency GLP-1 and GIP receptor agonism to unlock insights into complex metabolic interactions. This research-grade peptide, with its 15mg formulation, enables scientists to explore supra-therapeutic dosing effects, treatment-resistant metabolic conditions, and multi-hormonal pathway crosstalk—making it indispensable for cutting-edge preclinical investigations.
Why Tirzepatide 15mg is a Research Game-Changer
Unlike single-agonist peptides, Tirzepatide 15mg delivers dual-receptor activation, amplifying insulin secretion, suppressing glucagon release, and enhancing satiety signaling through synergistic GLP-1 and GIP pathways. Its 15mg concentration is uniquely designed for studies requiring maximal receptor stimulation, allowing researchers to map dose-response curves, identify biological thresholds, and investigate extreme metabolic responses in preclinical models.
Key Research Applications
Treatment-Resistant Metabolic Disorders
Perfect for investigating severe type 2 diabetes and refractory obesity, Tirzepatide 15mg facilitates research into enhanced glycemic control, rapid weight reduction, and improved insulin sensitivity under high-dose conditions. It supports analysis of multi-hormonal interactions in resistant phenotypes, offering insights into novel therapeutic strategies.
Multi-Organ Metabolic Crosstalk
This formulation enables exploration of systemic metabolic links, from adipose tissue regulation to cardiovascular-renal axis impacts. Researchers can study accelerated lipid metabolism, reduced hepatic steatosis, and arterial stiffness modulation—critical for understanding metabolic comorbidities in advanced disease states.
Produkspesifikasies
Each vial contains 15mg of lyophilized Tirzepatide with ≥99% purity, ensuring consistent research results. Requires reconstitution with bacteriostatic water (Afsonderlik verkoop). Slegs vir navorsing gebruik—not approved for human or animal administration.
Tirzepatide 15mg empowers scientists to push metabolic research boundaries, offering unprecedented insights into dual-agonist therapy potential for addressing global health challenges through rigorous preclinical investigation.
Los jou boodskap